Features | DFS | OS | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
CDX2 expression | ||||
 High | 1 (reference) |  | 1 (reference) |  |
 Low | 1.64 (1.08–2.38) | 0.02 | 2.41 (1.52–3.85) | < 0.001 |
Sex | ||||
 Female | 1 (reference) |  | 1 (reference) |  |
 Male | 0.96 (0.73–1.24) | 0.74 | 0.94 (0.65–1.34) | 0.74 |
Tumor grade | ||||
 Well | 1 (reference) |  | 1 (reference) |  |
 Mod | 1.04 (0.73–1.47) | 0.83 | 1.29 (0.79–2.10) | 0.30 |
 Por | 1.24 (0.68–2.28) | 0.48 | 1.73 (0.73–4.04) | 0.21 |
Pre- or post-operative chemotherapy | ||||
 No | 1 (reference) |  | 1 (reference) |  |
 Yes | 0.92 (0.68–1.22) | 0.55 | 1.58 (1.06–2.36) | 0.02 |
Tumor location | ||||
 Right | 1 (reference) |  | 1 (reference) |  |
 Left | 0.85 (0.62–1.17) | 0.33 | 0.67 (0.44–1.01) | 0.06 |
 Rectum | 0.97 (0.71–1.37) | 0.97 | 0.63 (0.68–1.05) | 0.08 |
Liver metastasis | ||||
 Synchronous | 1 (reference) |  | 1 (reference) |  |
 Metachronous | 0.59 (0.45–0.77) | < 0.001 | 1.25 (0.88–1.79) | 0.20 |